Sunday, May 11, 2025 5/11/2025

Brain-gut-immune Profiling in Connective Tissue Disorder-related Gastrointestinal Dysfunction

Award Number: R03DK131221
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Description

Brain-gut-immune Profiling in Connective Tissue Disorder-related Gastrointestinal Dysfunction - PROJECT SUMMARY/ABSTRACT Hypermobile Ehlers-Danlos Syndrome (hEDS) and Hypermobility Spectrum Disorders (HSD) are prevalent but underdiagnosed conditions associated with excess morbidity. Despite improved recognition, many patients are still misdiagnosed with chronic fatigue syndrome, fibromyalgia, psychosomatic and functional GI disorders etc. There is now ample data linking hEDS/HSD with `functional' GI symptoms and disordered autonomic nervous system (ANS) control. However, little is known about the pathophysiology that connects these disabling comorbidities. A complete lack of targeted treatment options naturally follows the paucity of mechanistic data. A dysregulated ANS response circuit is closely linked to enhanced GI visceral hypersensitivity. This bio- evolutionary model of the ANS is described in the Polyvagal Theory (Porges 1995) and aligns well with the aberrant brain-gut axis concept of functional disorders of gut-brain interaction (DGBIs). This hyperreactivity to bodily perturbations, controlled by brainstem nuclei that regulate organ function, can be non-invasively measured via validated indices of cardiac vagal tone (vagal efficiency and respiratory sinus arrhythmia). Using these measures, we have recently documented a poor vagal tone in adolescents with HSD. No studies have yet explained how cardiac inhibitory signals may be dysregulated in hEDS/HSD patients with apparent `functional' digestive symptoms. There is paucity of data on the role of inflammation in hEDS/HSD with DGBIs. Our preliminary data from dermal fibroblasts in hEDS demonstrate abnormal TGF-β signaling, an important cytokine regulator. Further, the frequent meal-related symptoms may signal an underlying gastric motor disturbance not captured by current tests. Multimodal assessment of gastric physiology (contractility, accommodation, emptying and blood flow in response to meal) can now be assessed with a novel gastric MRI protocol. Simultaneous pre- and post- meal ANS function testing may further delineate brain-gut axis alterations. This feasibility study will investigate the brain-gut-immune axis along with transcriptome studies to detect variants predisposing to tissue and blood vessel laxity in adolescents with hEDS/HSD and functional GI complaints. We will investigate ANS function measures (Aim 1), cytokine profiling and RNASeq of duodenal fibroblasts (Aim 2), as well as dynamic gastric MRI (Aim 3) in a small cohort of females compared to healthy controls. The proposed studies provide an integrative model for a common, multi-system disorder that may underlie a subset of DGBIs. Data from this study may address an important scientific knowledge gap that crosses multiple medical disciplines.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = -$16,689 )
2024	2023	THE MEDICAL COLLEGE OF WISCONSIN, INC.	8701 WATERTOWN PLANK RD	MILWAUKEE	WI	53226	MILWAUKEE	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	2	6/11/2024	NON-COMPETING CONTINUATION	-$16,689
														Subtotal = -$16,689

Issue Date FY: 2023 ( Subtotal = $100,614 )
2023	2023	MEDICAL COLLEGE OF WISCONSIN, INC., THE	8701 WATERTOWN PLANK RD	MILWAUKEE	WI	53226	MILWAUKEE	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	2	1/20/2023	NON-COMPETING CONTINUATION	$100,614
														Subtotal = $100,614

Issue Date FY: 2022 ( Subtotal = $95,196 )
2022	2022	MEDICAL COLLEGE OF WISCONSIN, INC., THE	8701 WATERTOWN PLANK RD	MILWAUKEE	WI	53226	MILWAUKEE	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	1/14/2022	NEW	$95,196
														Subtotal = $95,196

Grand Total All Awards = $179,121

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Brain-gut-immune Profiling in Connective Tissue Disorder-related Gastrointestinal Dysfunction

Award Number: R03DK131221

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer